Director, Center for Vein Disease
Englewood Hospital and Medical Center
Englewood, New Jersey
Presenter
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
Presenter
SESSION 71: SUPERFICIAL VEIN TREATMENT STRATEGIES VI
Presenter
SESSION 68: SUPERFICIAL VEIN TREATMENT STRATEGIES III
Session Moderator
SESSION 101: MORE VENOUS THROMBOSIS
Presenter
SESSION 100: PELVIC VEIN DISORDERS
Presenter
SESSION 101: MORE VENOUS THROMBOSIS
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
Decision Making In Saphenous Ablation: What To Use And When
9:58 AM - 10:03 AM
Presenter
SESSION 71: SUPERFICIAL VEIN TREATMENT STRATEGIES VI
Mechanical Occlusion Segmental Chemical Ablation (MOSCA): Animal Study With Wavella Device
4:55 PM - 5:00 PM
Presenter
SESSION 68: SUPERFICIAL VEIN TREATMENT STRATEGIES III
VEINRESET: US Multicenter HIFU Trial: 6-Month Results
12:01 PM - 12:05 PM
Session Moderator
SESSION 101: MORE VENOUS THROMBOSIS
Presenter
SESSION 100: PELVIC VEIN DISORDERS
Management Of Symptomatic Vulvar Varices With And Without Pelvic Symptoms
1:10 PM - 1:15 PM
Presenter
SESSION 101: MORE VENOUS THROMBOSIS
SVT Treatment Options: DOAC, LMWH, Nothing
2:28 PM - 2:33 PM
CONTROVERSIES IN VENOUS DISEASE MANAGEMENT
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
11:25 AM - 11:30 AM
Most Perforators Should Be Ablated
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
11:25 AM - 11:30 AM
Most Perforators Should Be Ablated